Linden Capital Partners Acquires Collagen Matrix, Inc.

Collagen Matrix Acquires Polyganics

October 5, 2022

Medical Devices

Collagen Matrix, a Linden Capital Partners portfolio company, has acquired Polyganics B.V., a Netherlands-based developer and manufacturer of bioresorbable medical devices. The add-on acquisition expands Collagen Matrix's regenerative medicine and polymer capabilities, entering new clinical verticals such as ENT and general surgery and broadening its neurosurgery and peripheral nerve offerings.

Collagen Matrix Acquires GUIDOR Synthetic Bone Graft & Membrane Business from Sunstar

December 29, 2020

Medical Devices

Collagen Matrix, a Linden Capital Partners portfolio company, has acquired Sunstar's Degradable Solutions division, including the GUIDOR-branded synthetic bone graft substitutes and bioresorbable membranes. The acquisition expands Collagen Matrix's regenerative product portfolio and electrospinning capabilities to support new combination products and broader dental market applications.

Linden Capital Partners Acquires Avalign Technologies; Harvest Partners SCF Invests to Support Transaction

January 9, 2019

Medical Devices

Linden Capital Partners has acquired Avalign Technologies from Arlington Capital Partners, with Harvest Partners SCF, LP providing a non-control investment to support the transaction. Avalign, based in Bannockburn, Illinois, is a full-service manufacturer and distributor of orthopedic implants, specialty surgical instruments, proprietary coatings and related surgical systems; the buyers cited support for continued organic growth and M&A-driven value creation.

Linden Capital Partners Invests in Formulated Solutions

September 28, 2021

Healthcare Services

Chicago-based private equity firm Linden Capital Partners has invested in Formulated Solutions, a Largo, Florida CDMO that provides contract development and manufacturing services for OTC and Rx topical and nasal products. The investment was completed alongside current shareholders including the founding Dann Family and HealthEdge Investment Partners, with Linden principals joining the company's board and Twin Brook Capital Partners providing debt financing.

Linden Capital Partners Acquires Alcresta Therapeutics

March 12, 2024

Medical Devices

Chicago-based private equity firm Linden Capital Partners has completed its acquisition of Alcresta Therapeutics from a group led by Athyrium Capital, with Bessemer Venture Partners, Frazier Healthcare Partners and HealthQuest Capital also selling (HealthQuest reinvested as a minority shareholder). Linden will work with Alcresta's management and a newly assembled board to support the commercial launch of the next-generation RELiZORB device and accelerate R&D and growth.

RTI Surgical Acquires Collagen Solutions

October 7, 2024

Medical Devices

RTI Surgical, a Montagu-backed CDMO, has agreed to acquire Collagen Solutions, a global supplier of engineered medical-grade collagen and xenograft tissue, expanding RTI's soft-tissue biomaterials capabilities. The acquisition broadens RTI's access to high-growth therapeutic areas including cardiac, sports medicine and orthopedics, and plastic and reconstructive surgery; Collagen Solutions is headquartered in Eden Prairie, Minnesota with additional sites in the U.K. and New Zealand.